200 related articles for article (PubMed ID: 9626136)
1. Polymerase chain reaction-based microsatellite polymorphism analysis of follicular and Hürthle cell neoplasms of the thyroid.
Segev DL; Saji M; Phillips GS; Westra WH; Takiyama Y; Piantadosi S; Smallridge RC; Nishiyama RH; Udelsman R; Zeiger MA
J Clin Endocrinol Metab; 1998 Jun; 83(6):2036-42. PubMed ID: 9626136
[TBL] [Abstract][Full Text] [Related]
2. Polymerase chain reaction-based microsatellite analysis of fine-needle aspirations from Hürthle cell neoplasms.
Takiyama Y; Saji M; Clark DP; Phillips GS; Segev DL; Smallridge RC; Westra WH; Udelsman R; Zeiger MA
Thyroid; 1997 Dec; 7(6):853-7. PubMed ID: 9459628
[TBL] [Abstract][Full Text] [Related]
3. Biological differential diagnosis of follicular thyroid tumor and Hürthle cell tumor on the basis of telomere length and hTERT expression.
Sugishita Y; Kammori M; Yamada O; Yamazaki K; Ito K; Fukumori T; Yoshikawa K; Yamada T
Ann Surg Oncol; 2014 Jul; 21(7):2318-25. PubMed ID: 24562933
[TBL] [Abstract][Full Text] [Related]
4. Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid.
Máximo V; Preto A; Crespo A; Rocha AS; Machado JC; Soares P; Sobrinho-Simões M
BMC Cancer; 2004 Mar; 4():12. PubMed ID: 15043758
[TBL] [Abstract][Full Text] [Related]
5. High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene.
Farrand K; Delahunt B; Wang XL; McIver B; Hay ID; Goellner JR; Eberhardt NL; Grebe SK
J Clin Endocrinol Metab; 2002 Oct; 87(10):4715-21. PubMed ID: 12364463
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal aberrations by comparative genomic hybridization in hürthle cell thyroid carcinomas are associated with tumor recurrence.
Wada N; Duh QY; Miura D; Brunaud L; Wong MG; Clark OH
J Clin Endocrinol Metab; 2002 Oct; 87(10):4595-601. PubMed ID: 12364440
[TBL] [Abstract][Full Text] [Related]
7. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
8. [Follicular and Hurthle cell tumors of the thyroid gland. Possibilities of preoperative differential diagnosis].
Grineva EN; Goriushkina EV; Malakhova TV; Tsoĭ UA
Vopr Onkol; 2004; 50(1):41-5. PubMed ID: 15088519
[TBL] [Abstract][Full Text] [Related]
9. Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas.
Ward LS; Brenta G; Medvedovic M; Fagin JA
J Clin Endocrinol Metab; 1998 Feb; 83(2):525-30. PubMed ID: 9467569
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of Hurthle cell neoplasms by gene profiling.
Finley DJ; Zhu B; Fahey TJ
Surgery; 2004 Dec; 136(6):1160-8. PubMed ID: 15657571
[TBL] [Abstract][Full Text] [Related]
11. Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas.
Nascimento MC; Bisi H; Alves VA; Longatto-Filho A; Kanamura CT; Medeiros-Neto G
Endocr Pathol; 2001; 12(3):275-9. PubMed ID: 11740048
[TBL] [Abstract][Full Text] [Related]
12. Hürthle cell neoplasms diagnosed by fine needle aspiration are not associated with an increased risk of malignancy.
McKee S; Wu H; Wang X; Cramer H; Lin J; Chen S
Acta Cytol; 2014; 58(3):235-8. PubMed ID: 24819535
[TBL] [Abstract][Full Text] [Related]
13. Allelotype of follicular thyroid carcinomas reveals genetic instability consistent with frequent nondisjunctional chromosomal loss.
Tung WS; Shevlin DW; Kaleem Z; Tribune DJ; Wells SA; Goodfellow PJ
Genes Chromosomes Cancer; 1997 May; 19(1):43-51. PubMed ID: 9135994
[TBL] [Abstract][Full Text] [Related]
14. Management of follicular and Hürthle cell neoplasms of the thyroid gland.
McHenry CR; Sandoval BA
Surg Oncol Clin N Am; 1998 Oct; 7(4):893-910. PubMed ID: 9735140
[TBL] [Abstract][Full Text] [Related]
15. HMGA2 expression analysis in cytological and paraffin-embedded tissue specimens of thyroid tumors by relative quantitative RT-PCR.
Jin L; Lloyd RV; Nassar A; Lappinga PJ; Sebo TJ; Swartz K; Seys AR; Erickson-Johnson MR; Roth CW; Evers BR; Oliveira AM; Zhang J
Diagn Mol Pathol; 2011 Jun; 20(2):71-80. PubMed ID: 21532495
[TBL] [Abstract][Full Text] [Related]
16. Frequent chromosomal DNA unbalance in thyroid oncocytic (Hürthle cell) neoplasms detected by comparative genomic hybridization.
Tallini G; Hsueh A; Liu S; Garcia-Rostan G; Speicher MR; Ward DC
Lab Invest; 1999 May; 79(5):547-55. PubMed ID: 10334566
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylated Mechanistic Target of Rapamycin (p-mTOR) and Noncoding RNA Expression in Follicular and Hürthle Cell Thyroid Neoplasm.
Covach A; Patel S; Hardin H; Lloyd RV
Endocr Pathol; 2017 Sep; 28(3):207-212. PubMed ID: 28660408
[TBL] [Abstract][Full Text] [Related]
18. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis.
Elliott DD; Pitman MB; Bloom L; Faquin WC
Cancer; 2006 Apr; 108(2):102-9. PubMed ID: 16453320
[TBL] [Abstract][Full Text] [Related]
19. The value of frozen section in intraoperative surgical management of thyroid follicular carcinoma.
Dosen D; Turić M; Smalcelj J; Janusić R; Grgić MP; Separović V
Head Neck; 2003 Jul; 25(7):521-8. PubMed ID: 12808654
[TBL] [Abstract][Full Text] [Related]
20. PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses.
Nikiforova MN; Biddinger PW; Caudill CM; Kroll TG; Nikiforov YE
Am J Surg Pathol; 2002 Aug; 26(8):1016-23. PubMed ID: 12170088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]